Prioritising neonatal medicines research: UK Medicines for Children Research Network scoping survey
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2431
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Prioritising neonatal medicines research: UK Medicines for Children Research Network scoping survey ; volume:9 ; number:1 ; day:12 ; month:8 ; year:2009 ; pages:1-5 ; date:12.2009
BMC pediatrics ; 9, Heft 1 (12.8.2009), 1-5, 12.2009
- Urheber
-
Turner, Mark A.
- Beteiligte Personen und Organisationen
-
Lewis, Sara
Hawcutt, Daniel B.
Field, D.
SpringerLink (Online service)
- DOI
-
10.1186/1471-2431-9-50
- URN
-
urn:nbn:de:1111-2016081311203
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:04 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Turner, Mark A.
- Lewis, Sara
- Hawcutt, Daniel B.
- Field, D.
- SpringerLink (Online service)
Ähnliche Objekte (12)
The FIMP Medicines for Children Research Network
Successful private–public funding of paediatric medicines research: lessons from the EU programme to fund research into off-patent medicines
Network medicines™
A research agenda to promote affordable and quality assured medicines
Ocular medicines in children: the regulatory situation related to clinical research
Traditional medicines as a mechanism for driving research innovation in Africa
Review on Experimental Research of Herbal Medicines with Anti-Amnesic Activity
Review: UK medicines likely to be affected by the proposed European Medicines Agency’s guidelines on phthalates
Translational medicines “Ecosystem”
Evidence-based quality criteria in research, development and application of Chinese medicines
Regulations Governing Medicines for Maternal and Neonatal Health: A Landscape Assessment
Excellence in Family Paediatricians: the FIMP-MCRN (Medicines for Children Research Network) becomes a member of ENPR-EMA (European Network of Paediatric Research at the European Medicines Agency)
The FIMP Medicines for Children Research Network
Successful private–public funding of paediatric medicines research: lessons from the EU programme to fund research into off-patent medicines
Network medicines™
A research agenda to promote affordable and quality assured medicines
Ocular medicines in children: the regulatory situation related to clinical research
Traditional medicines as a mechanism for driving research innovation in Africa
Review on Experimental Research of Herbal Medicines with Anti-Amnesic Activity
Review: UK medicines likely to be affected by the proposed European Medicines Agency’s guidelines on phthalates
Translational medicines “Ecosystem”
Evidence-based quality criteria in research, development and application of Chinese medicines
Regulations Governing Medicines for Maternal and Neonatal Health: A Landscape Assessment
Excellence in Family Paediatricians: the FIMP-MCRN (Medicines for Children Research Network) becomes a member of ENPR-EMA (European Network of Paediatric Research at the European Medicines Agency)
The FIMP Medicines for Children Research Network
Successful private–public funding of paediatric medicines research: lessons from the EU programme to fund research into off-patent medicines
Network medicines™
A research agenda to promote affordable and quality assured medicines
Ocular medicines in children: the regulatory situation related to clinical research
Traditional medicines as a mechanism for driving research innovation in Africa
Review on Experimental Research of Herbal Medicines with Anti-Amnesic Activity
Review: UK medicines likely to be affected by the proposed European Medicines Agency’s guidelines on phthalates
Translational medicines “Ecosystem”
Evidence-based quality criteria in research, development and application of Chinese medicines
Regulations Governing Medicines for Maternal and Neonatal Health: A Landscape Assessment